Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 6/2015

01-11-2015 | Original Article

The impact of LRP5 polymorphism (rs556442) on calcium homeostasis, bone mineral density, and body composition in Iranian children

Authors: Elham Ashouri, Elham Mahmoodi Meimandi, Forough Saki, Mohammad Hossein Dabbaghmanesh, Gholamhossein Ranjbar Omrani, Marzieh Bakhshayeshkaram

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2015

Login to get access

Abstract

Failure to achieve optimal bone mass in childhood is the primary cause of decreased adult bone mineral density (BMD) and increased bone fragility in later life. Activating and inactivating LRP5 gene mutations has been associated with extreme bone-related phenotypes. Our aim was to investigate the role of LRP5 polymorphism on BMD, mineral biochemical parameters, and body composition in Iranian children. This cross-sectional study was performed on 9–18 years old children (125 boys, 137 girls). The serum level of calcium, phosphorous, alkaline phosphatase, and vitamin D parameters were checked. The body composition and BMD variables were measured by the Hologic system DXA. The rs566442 (V1119V) coding polymorphism in exon 15 of LRP5 was performed using PCR–RFLP method. Linear regression analysis, with adjustment for age, gender, body size parameters, and pubertal status was used to determine the association between LRP5 polymorphism (rs556442) and bone and body composition parameters. The allele frequency of the rs566442 gene was 35.5 % A and 63.9 % G. Our study revealed that LRP5 (rs556442) has not any significant influence on serum calcium, phosphorus, 25OHvitD, and serum alkaline phosphatase (P > 0.05). Total lean mass was greater in GG genotype (P = 0.028). Total body less head area (P = 0.044), spine BMD (P = 0.04), and total femoral BMC (P = 0.049) were lower in AG heterozygote genotype. This study show LRP5 polymorphism may associate with body composition and BMD in Iranian children. However, further investigations should be done to evaluate the role of other polymorphism.
Literature
1.
go back to reference Rosen C (2000) Pathogenesis of osteoporosis. Ballieres Clin Endocrinol Metab 14:181–193 Rosen C (2000) Pathogenesis of osteoporosis. Ballieres Clin Endocrinol Metab 14:181–193
2.
go back to reference Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R (1999) Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 84:4702–4712PubMed Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R (1999) Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 84:4702–4712PubMed
4.
go back to reference Riancho JA, Olmos JM, Pineda B, García-Ibarbia C, Pérez-Núñez MI et al (2011) Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication. Eur J Endocrinol 164:123–131CrossRefPubMed Riancho JA, Olmos JM, Pineda B, García-Ibarbia C, Pérez-Núñez MI et al (2011) Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication. Eur J Endocrinol 164:123–131CrossRefPubMed
5.
go back to reference Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA et al (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825–837PubMedCentralCrossRefPubMed Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA et al (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825–837PubMedCentralCrossRefPubMed
6.
go back to reference Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL et al (2004) Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19:1619–1627CrossRefPubMed Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL et al (2004) Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19:1619–1627CrossRefPubMed
7.
go back to reference Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE (2004) Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74:866–875PubMedCentralCrossRefPubMed Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE (2004) Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74:866–875PubMedCentralCrossRefPubMed
8.
go back to reference Koay MA, Tobias JH, Leary SD, Steer CD, Vilariño-Güell C et al (2007) The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcif Tissue Int 81:1–9PubMedCentralCrossRefPubMed Koay MA, Tobias JH, Leary SD, Steer CD, Vilariño-Güell C et al (2007) The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcif Tissue Int 81:1–9PubMedCentralCrossRefPubMed
9.
go back to reference Utriainen P, Jääskeläinen J, Saarinen A, Vanninen E, Mäkitie O et al (2009) Body composition and bone mineral density in children with premature adrenarche and the association of LRP5 gene polymorphisms with bone mineral density. J Clin Endocrinol Metab 94:4144–4151CrossRefPubMed Utriainen P, Jääskeläinen J, Saarinen A, Vanninen E, Mäkitie O et al (2009) Body composition and bone mineral density in children with premature adrenarche and the association of LRP5 gene polymorphisms with bone mineral density. J Clin Endocrinol Metab 94:4144–4151CrossRefPubMed
10.
go back to reference Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Bénichou O et al (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763–771PubMedCentralCrossRefPubMed Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Bénichou O et al (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763–771PubMedCentralCrossRefPubMed
11.
go back to reference Korvala J, Jüppner H, Mäkitie O, Sochett E, Schnabel D et al (2012) Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med Genet 10:26CrossRef Korvala J, Jüppner H, Mäkitie O, Sochett E, Schnabel D et al (2012) Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med Genet 10:26CrossRef
12.
go back to reference Jeddi M, Roosta MJ, Dabbaghmanesh MH, Omrani GR, Ayatollahi SM et al (2013) Normative data and percentile curves of bone mineral density in healthy Iranian children aged 9–18 years. Arch Osteoporos 8:114CrossRefPubMed Jeddi M, Roosta MJ, Dabbaghmanesh MH, Omrani GR, Ayatollahi SM et al (2013) Normative data and percentile curves of bone mineral density in healthy Iranian children aged 9–18 years. Arch Osteoporos 8:114CrossRefPubMed
13.
go back to reference Fretz JA, Zella LA, Kim S, Shevde NK, Pike JW (2007) 1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene’s transcriptional start site. J Steroid Biochem Mol Biol 103:440–445PubMedCentralCrossRefPubMed Fretz JA, Zella LA, Kim S, Shevde NK, Pike JW (2007) 1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene’s transcriptional start site. J Steroid Biochem Mol Biol 103:440–445PubMedCentralCrossRefPubMed
14.
go back to reference Pike JW, Meyer MB, Watanuki M, Kim S, Zella LA et al (2007) Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J Steroid Biochem Mol Biol 103:389–395PubMedCentralCrossRefPubMed Pike JW, Meyer MB, Watanuki M, Kim S, Zella LA et al (2007) Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J Steroid Biochem Mol Biol 103:389–395PubMedCentralCrossRefPubMed
15.
go back to reference Kubota T, Michigami T, Ozono K (2009) Wnt signaling in bone metabolism. J Bone Miner Metab 27:265–271CrossRefPubMed Kubota T, Michigami T, Ozono K (2009) Wnt signaling in bone metabolism. J Bone Miner Metab 27:265–271CrossRefPubMed
16.
go back to reference Li Y, Sun CH, Yin H, Chen YF (2006) Association of polymorphism of low density lipoprotein receptor-related protein 5 Q89R, A1330V with bone mineral density in premenopausal northern Chinese women. Wei Sheng Yan Jiu 35:576–579PubMed Li Y, Sun CH, Yin H, Chen YF (2006) Association of polymorphism of low density lipoprotein receptor-related protein 5 Q89R, A1330V with bone mineral density in premenopausal northern Chinese women. Wei Sheng Yan Jiu 35:576–579PubMed
17.
go back to reference Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N et al (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277:30998–31004CrossRefPubMed Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N et al (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277:30998–31004CrossRefPubMed
18.
go back to reference Ross SE, Hemati N, Longo KA, Bennett CN, Lucas P et al (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950–953CrossRefPubMed Ross SE, Hemati N, Longo KA, Bennett CN, Lucas P et al (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950–953CrossRefPubMed
20.
go back to reference Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA et al (2002) Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 123:649–661CrossRefPubMed Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA et al (2002) Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 123:649–661CrossRefPubMed
22.
go back to reference Tanner J (1986) Normal growth and techniques of growth assessment. Clin Endocrinol Metab 15:411–451CrossRefPubMed Tanner J (1986) Normal growth and techniques of growth assessment. Clin Endocrinol Metab 15:411–451CrossRefPubMed
23.
go back to reference Jones G, Deqiong M, Cameron F (2006) Bone density interpretation and relevance in Caucasian children aged 9–17 years of age: insights from a population-based fracture study. J Clin Densitom 9:202–209CrossRefPubMed Jones G, Deqiong M, Cameron F (2006) Bone density interpretation and relevance in Caucasian children aged 9–17 years of age: insights from a population-based fracture study. J Clin Densitom 9:202–209CrossRefPubMed
25.
go back to reference Mckay HA, Petit MA, Bailey DA, Wallace WM, Schutz RW (2000) Analysis of proximal femur DXA scans in growing children: comparisons of different protocols for cross-sectional 8-month and 7-year longitudinal data. J Bone Miner Res 15:1181–1188CrossRefPubMed Mckay HA, Petit MA, Bailey DA, Wallace WM, Schutz RW (2000) Analysis of proximal femur DXA scans in growing children: comparisons of different protocols for cross-sectional 8-month and 7-year longitudinal data. J Bone Miner Res 15:1181–1188CrossRefPubMed
26.
go back to reference Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137–145CrossRefPubMed Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137–145CrossRefPubMed
27.
go back to reference Cole JH, Scerpella TA, van der Meulen MC (2005) Fan-beam densitometry of the growing skeleton. J Clin Densitom 8:57–64CrossRefPubMed Cole JH, Scerpella TA, van der Meulen MC (2005) Fan-beam densitometry of the growing skeleton. J Clin Densitom 8:57–64CrossRefPubMed
28.
go back to reference Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319CrossRefPubMed Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319CrossRefPubMed
29.
go back to reference Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T et al (2005) LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 36:599–606CrossRefPubMed Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T et al (2005) LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 36:599–606CrossRefPubMed
30.
go back to reference Guo YF, Xiong DH, Shen H, Zhao LJ, Xiao P et al (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 43:798–803PubMedCentralCrossRefPubMed Guo YF, Xiong DH, Shen H, Zhao LJ, Xiao P et al (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 43:798–803PubMedCentralCrossRefPubMed
31.
go back to reference Balemans W, Van Hul W (2007) The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology 148:2622–2629CrossRefPubMed Balemans W, Van Hul W (2007) The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology 148:2622–2629CrossRefPubMed
32.
go back to reference Kashef S, Saki F, Karamizadeh Z, Kashef MA (2006) Bone mineral density in children with systemic lupus erythematosus and juvenile rheumatoid arthritis. Ann Saudi Med 27:427–431CrossRef Kashef S, Saki F, Karamizadeh Z, Kashef MA (2006) Bone mineral density in children with systemic lupus erythematosus and juvenile rheumatoid arthritis. Ann Saudi Med 27:427–431CrossRef
33.
go back to reference Riddle RC, Diegel CR, Leslie JM, Van Koevering KK, Faugere MC, Clemens TL, Williams BO (2013) Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition. PLoS One 8:e63323PubMedCentralCrossRefPubMed Riddle RC, Diegel CR, Leslie JM, Van Koevering KK, Faugere MC, Clemens TL, Williams BO (2013) Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition. PLoS One 8:e63323PubMedCentralCrossRefPubMed
Metadata
Title
The impact of LRP5 polymorphism (rs556442) on calcium homeostasis, bone mineral density, and body composition in Iranian children
Authors
Elham Ashouri
Elham Mahmoodi Meimandi
Forough Saki
Mohammad Hossein Dabbaghmanesh
Gholamhossein Ranjbar Omrani
Marzieh Bakhshayeshkaram
Publication date
01-11-2015
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 6/2015
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-014-0624-4

Other articles of this Issue 6/2015

Journal of Bone and Mineral Metabolism 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine